UNICA IRIS Institutional Research Information System

CAOCCI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 498.384
NA - Nord America 19.744
AS - Asia 9.649
SA - Sud America 1.641
AF - Africa 247
OC - Oceania 64
Continente sconosciuto - Info sul continente non disponibili 11
Totale 529.740
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 488.088
US - Stati Uniti d'America 19.379
NL - Olanda 5.127
SG - Singapore 3.733
CN - Cina 3.042
BR - Brasile 1.266
SE - Svezia 1.263
UA - Ucraina 1.158
VN - Vietnam 995
FI - Finlandia 699
GB - Regno Unito 519
DE - Germania 510
FR - Francia 503
HK - Hong Kong 373
IN - India 332
KR - Corea 218
CA - Canada 209
BD - Bangladesh 159
AR - Argentina 137
IQ - Iraq 111
AT - Austria 92
MX - Messico 92
JP - Giappone 87
TR - Turchia 78
ZA - Sudafrica 76
PL - Polonia 74
RU - Federazione Russa 73
EC - Ecuador 65
PK - Pakistan 64
AU - Australia 55
IR - Iran 54
ID - Indonesia 49
SA - Arabia Saudita 46
VE - Venezuela 45
IE - Irlanda 44
MY - Malesia 42
ES - Italia 38
MA - Marocco 37
BE - Belgio 32
CO - Colombia 32
PH - Filippine 32
UZ - Uzbekistan 27
AE - Emirati Arabi Uniti 26
CL - Cile 25
EG - Egitto 24
JO - Giordania 23
CZ - Repubblica Ceca 22
TH - Thailandia 22
PY - Paraguay 21
CH - Svizzera 19
KE - Kenya 19
LT - Lituania 19
TN - Tunisia 19
PE - Perù 18
IL - Israele 17
UY - Uruguay 17
ET - Etiopia 16
JM - Giamaica 16
RO - Romania 16
DZ - Algeria 15
AZ - Azerbaigian 14
BO - Bolivia 13
KZ - Kazakistan 13
OM - Oman 13
NP - Nepal 12
BG - Bulgaria 11
DK - Danimarca 11
EU - Europa 11
LB - Libano 10
TW - Taiwan 10
PS - Palestinian Territory 9
BY - Bielorussia 8
NZ - Nuova Zelanda 8
PA - Panama 8
PT - Portogallo 8
CR - Costa Rica 7
GE - Georgia 7
HU - Ungheria 7
NG - Nigeria 7
PR - Porto Rico 7
DO - Repubblica Dominicana 6
GR - Grecia 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
KG - Kirghizistan 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
AM - Armenia 4
CI - Costa d'Avorio 4
HR - Croazia 4
LV - Lettonia 4
MD - Moldavia 4
MU - Mauritius 4
NI - Nicaragua 4
NO - Norvegia 4
QA - Qatar 4
RS - Serbia 4
BW - Botswana 3
CG - Congo 3
HN - Honduras 3
Totale 529.690
Salva come PNG Salva come JPEG
Città #
Cagliari 459.971
Uta 26.252
Amsterdam 5.042
Singapore 1.798
Ashburn 1.780
Fairfield 1.726
Woodbridge 1.328
San Jose 1.145
Dallas 1.073
Boardman 980
Houston 892
Chandler 846
Wilmington 711
Nyköping 709
Seattle 704
Ann Arbor 689
Cambridge 618
Jacksonville 597
Beijing 581
Helsinki 474
Los Angeles 464
New York 443
Council Bluffs 393
Hong Kong 331
Ho Chi Minh City 298
Lauterbourg 273
Hefei 269
Nanjing 217
Santa Clara 216
Boston 215
Seoul 199
Hanoi 177
Dong Ket 170
Milan 169
Shanghai 165
Rome 160
The Dalles 156
Buffalo 152
Dearborn 126
San Diego 122
São Paulo 117
Chicago 99
Guangzhou 94
Orem 88
Redondo Beach 84
Atlanta 82
Toronto 74
Munich 71
London 70
Redwood City 67
Shenyang 67
Tokyo 62
Nanchang 61
Phoenix 61
Tianjin 61
Hebei 59
Chennai 58
Frankfurt am Main 58
Menlo Park 58
Nuremberg 57
Rio de Janeiro 57
Changsha 56
Mountain View 56
Warsaw 54
Brooklyn 53
Denver 52
Norwalk 45
Vienna 43
Baghdad 42
Washington 42
Da Nang 41
Johannesburg 41
Haiphong 39
Jiaxing 39
Manchester 36
San Francisco 36
Montreal 35
Pune 35
Verona 35
Orange 33
Jinan 32
Sassari 32
Falls Church 29
Mumbai 29
Brussels 28
Lappeenranta 28
Wuhan 28
Zhengzhou 27
Hangzhou 26
Paris 26
Tashkent 26
Shenzhen 25
New Delhi 24
Stockholm 24
Düsseldorf 23
Naples 23
Bologna 22
Poplar 22
Sydney 22
Dublin 21
Totale 515.466
Salva come PNG Salva come JPEG
Nome #
Patient-Physician Communication in Acute Myeloid Leukemia and Myelodysplastic Syndrome 242.324
Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis 4.572
Leucocyte classification for leukaemia detection using image processing techniques 3.593
HLA-G expression and role in advanced-stage classical Hodgkin lymphoma 3.585
Comparison Between an Artificial Neural Network and Logistic Regression in Predicting Long Term Kidney Transplantation Outcome 3.434
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.405
Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma 3.368
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients 3.349
What unrelated hematopoietic stem cell transplantation in thalassemia taught us about transplant immunogenetics 3.318
Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients 3.314
HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia 3.237
Reassessing the approach to informed consent: The case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients 3.053
Permanent Discontinuation of Tyrosine Kinase Inhibitor Frontline Therapy in Patients with Chronic Phase Chronic Myeloid Leukemia Patients during the First 36 Months of Treatment: A "Campus CML" Study 2.922
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation 2.915
Kir haplotype aa is a possible predictive marker of complete molecular response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia 2.828
Ruolo del trapianto allogenico nelle talassemie 2.786
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma 2.748
Absence of histological myopathy in chronic myeloid leukemia patients complaining of muscle spasms and myalgia during treatment with nilotinib 2.720
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 2.610
Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients 2.604
A genome-wide association study by ImmunoChip reveals potential modifiers in myelodysplastic syndromes 2.525
Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia 2.255
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.250
Health related quality of life in patients with onco-hematological diseases 2.237
Favourable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib 2.195
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis 2.126
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 2.118
Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes 2.114
Homozygosity for Killer Immunoglobin-like Receptor (KIR) Haplotype a Is Associated to Negative Interim Positron Emission Tomography (PET) and a Favourable Outcome in Hodgkin Lymphoma 2.058
Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients 1.993
Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia 1.961
Ruxolitinib therapy and telomere length in myelofibrosis 1.959
Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life 1.939
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice 1.878
Modulation of bone marrow microenvironment following ruxolitinib therapy in myelofibrosis 1.839
Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors 1.839
THE HLA-G 14-BP POLYMORPHISM IS AN INDEPENDENT GENETIC RISK MARKER OF LONG-TERM KIDNEY TRANSPLANTATION OUTCOME 1.814
Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission 1.805
The human leukocyte antigen-g 14-bp polymorphism is an independent genetic risk marker of long-term kidney transplantation outcome 1.760
null 1.759
Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review 1.752
Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting 1.681
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors 1.618
Thresholds for clinical importance were defined for the EORTC CAT Core - an adaptive measure of core quality of life domains in oncology clinical practice and research 1.596
Acute basophilic leukemia with U2AF1 mutation 1.595
Defibrotide in the COVID-19 coagulopathy: what is the timing? 1.585
Systemic Mastocytosis with Associated Primary Myelofibrosis 1.577
Unrelated bone marrow transplantation in Thalassemia. The experience of the Italian Bone Marrow transplant Group (GITMO) 1.555
T cell tyrosine phosphorylation response to transient redox stress 1.553
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib 1.536
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes 1.535
Erythroblast morphology in refractory anemia with ring sideroblasts and thrombocytosis 1.533
Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research 1.512
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study 1.506
Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? 1.486
Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: a case report 1.470
Successful and safe stem cell mobilization using plerixafor in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia 1.467
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency 1.460
Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation 1.451
Perls stain grade in bone marrow aspirate correlates with overall survival in low-risk myelodysplastic patients 1.449
Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors 1.443
null 1.419
Resolution of capillary leak syndrome by extracorporeal membrane oxygenation 1.411
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients 1.400
The usefulness of artificial neural networks in predicting the outcome of hematopoietic stem cell transplantation 1.368
Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy 1.347
Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia 1.343
Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm 1.338
Immunological deregulation in classic hodgkin lymphoma 1.324
A simulated case of chronic myeloid leukemia: the growing risk of Munchausen’s Syndrome by internet 1.322
Rectal involvement in pre-early T acute lymphoblastic leukemia 1.309
Comparison between an artificial neural network and logistic regression in predicting acute graft-versus-host disease following unrelated donor hematopoietic stem cell transplantation in thalassemia patients 1.303
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 1.296
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major 1.279
Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia 1.231
Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination 1.226
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: A multicentre, prospective, observational, cohort study 1.219
The role of inhibitory KIR 2DL5 in the outcome of autologous hematopoietic stem cell transplantation for multiple myeloma 1.217
White Blood Cell Count Nadir and Duration of Aplasia Do Not Associate with Treatment Outcome in Adult Patients with Acute Myeloid Leukemia Undergoing Intensive Chemotherapy 1.202
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes 1.193
The usefulness of artificial neural networks in predicting the outcome of hematopoietic stem cell transplantation: a crystal ball to foresee the future? 1.172
Evaluating the Thresholds for Clinical Importance of the EORTC QLQ-C15-PAL in Patients Receiving Palliative Treatment 1.153
null 1.138
Comparison between an artificial neural network and logistic regression in predicting acute graft-versus-host disease following unrelated haematopoietic stem cell transplantation 1.131
null 1.128
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index 1.116
null 1.110
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity 1.107
Complement-mediated oxidative damage of red cells impairs response to eculizumab in a G6PD-deficient patient with PNH 1.078
Paroxysmal nocturnal hemoglobinuria: clinical expression and response to treatment are modified by a unique interaction with co-existing glucose 6-phosphate dehydrogenase deficiency 1.059
Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)? 1.055
null 1.048
Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis 1.042
Health-related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: What have we learned? 1.041
Complement Activation in Paroxysmal Nocturnal Hemoglobinuria (PNH) Causes Oxidative Damage Which May Affect Response to Eculizumab 1.041
null 1.034
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study 1.021
Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors 1.017
Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial). 1.011
Occurrence of immune thrombocytopenic purpura in a patient with essential thrombocythemia: How the immune system can overcome a neoplastic clone 1.010
Totale 421.728
Salva come PNG Salva come JPEG
Categoria #
all - tutte 647.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 647.700
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.146 0 0 0 0 0 0 0 0 0 0 0 2.146
2021/202217.322 1.674 1.367 820 915 1.235 1.281 835 875 1.405 2.021 2.587 2.307
2022/202322.185 1.654 2.475 2.451 1.687 2.012 2.372 961 2.724 1.364 1.400 2.052 1.033
2023/202426.605 1.275 1.050 1.468 1.954 2.229 4.706 3.680 1.828 1.345 2.031 2.505 2.534
2024/2025293.370 9.854 102.071 155.748 7.048 3.270 4.843 3.908 332 895 3.804 684 913
2025/202621.900 1.171 924 2.326 1.763 1.268 1.233 4.821 908 3.348 1.901 1.106 1.131
Totale 530.815